The Korean World Conference on Lung Cancer (WCLC) is the largest academic conference in the field of lung cancer globally. It focuses on basic research in lung cancer, clinical treatment progress, and exploration of innovative therapies, serving as the core platform driving development in the lung cancer field. Noteworthy is that in recent years, an increasing number of Chinese studies have been showcased on this stage.

As one of the most influential global academic conferences in the field of lung cancer, the International Association for the Study of Lung Cancer's (IASLC) World Conference on Lung Cancer (WCLC) is not only an academic hall where doctors in the lung cancer field can learn about cutting-edge developments and understand the direction of diagnosis and treatment, but also an excellent stage for researchers in the lung cancer field to share their research findings and expand their international perspectives.

The Korean World Conference on Lung Cancer (WCLC) features over 50 oral abstract reports across 18 categories, focusing on the latest advancements in various fields of lung cancer risk control, biology, screening, local treatment, immunotherapy, targeted therapy, etc., presenting the annual major breakthroughs in lung cancer research.

At that time, experts and scholars from all over the world will gather together, through various forms such as keynote speeches, thematic discussions, and poster exchanges. The Korean World Conference on Lung Cancer (WCLC) will jointly discuss cutting-edge issues in precision medicine, immunotherapy, targeted therapy, early screening, patient management, and more in the lung cancer field.